ESR1 and ovarian cancer: Our recent study using ovarian cancer cell lines treated with specific SERMs showed opposing functions of ER subtypes on cell growth, suggesting specifically targeting ER subtypes using SERMs may offer women a new option when ER subtypes expression is known [10].